EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs

Hongshan Guo, Joanna A Vuille, Ben S Wittner, Emily M Lachtara, Yu Hou, Maoxuan Lin, Ting Zhao, Ayush T Raman, Hunter C Russell, Brittany A Reeves, Haley M Pleskow, Chin-Lee Wu und 10 weitere

Cell · 2023-06 · 186 (13) · 2765-2782.e28

DOI: 10.1016/j.cell.2023.05.028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2023-06. Verfasst von Hongshan Guo und 21 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20…. Hauptthemen laut MEDLINE: DNA Methylation, Prostatic Neoplasms. Die Arbeit wurde bisher 82-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, Howard Hughes Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationProstatic NeoplasmsAnimalsHumansMaleMiceCarcinogenesisDNAEpigenesis, GeneticNeoplastic Cells, Circulating

Stichwörter der Autor:innen

CD1ADNA hypomethylationIFI16NKT cellscirculating tumor cellsimmune surveillancelipid antigensprostate cancersingle-cell sequencingtumorigenesis

Substanzen

DNA

Autor:innen und Institutionen

  • Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.
  • Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA.
  • Evergrande Center for Immunologic Diseases, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
  • Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA 02129, USA; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA.

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • Howard Hughes Medical Institute

Zitieren

APA

Guo, H., Vuille, J. A., Wittner, B. S., Lachtara, E. M., Hou, Y., Lin, M., Zhao, T., Raman, A. T., Russell, H. C., Reeves, B. A., Pleskow, H. M., Wu, C. L., Gnirke, A., Meissner, A., Efstathiou, J. A., Lee, R. J., Toner, M., Aryee, M. J., Lawrence, M. S., …, & Haber, D. A. (2023). DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs. Cell, 186(13), 2765-2782.e28. https://doi.org/10.1016/j.cell.2023.05.028

Vancouver

Guo H, Vuille JA, Wittner BS, Lachtara EM, Hou Y, Lin M, et al. DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs. Cell. 2023;186(13):2765-2782.e28. doi:10.1016/j.cell.2023.05.028

BibTeX
@article{Guo2023,
  author = {Guo, Hongshan and Vuille, Joanna A and Wittner, Ben S and Lachtara, Emily M and Hou, Yu and Lin, Maoxuan and Zhao, Ting and Raman, Ayush T and Russell, Hunter C and Reeves, Brittany A and Pleskow, Haley M and Wu, Chin-Lee and Gnirke, Andreas and Meissner, Alexander and Efstathiou, Jason A and Lee, Richard J and Toner, Mehmet and Aryee, Martin J and Lawrence, Michael S and Miyamoto, David T and Maheswaran, Shyamala and Haber, Daniel A},
  title = {DNA hypomethylation silences anti-tumor immune genes in early prostate cancer and CTCs},
  journal = {Cell},
  year = {2023},
  volume = {186},
  number = {13},
  pages = {2765--2782.e28},
  doi = {10.1016/j.cell.2023.05.028}
}
Kostenlos starten →